Trademark: 88125992
Word

Status
Registered
Status Code
700
Status Date
Tuesday, August 18, 2020
Serial Number
88125992
Registration Number
6127305
Registration Date
Tuesday, August 18, 2020
Mark Type
2000
Filing Date
Thursday, September 20, 2018
Published for Opposition
Tuesday, December 31, 2019

Trademark Owner History
Kintor Pharmaceutical Limited - Original Registrant

Classifications
5 Medicines for treatment of cancer; sachets for pharmaceutical purposes, medicines in the form of capsules, chemico-pharmaceutical preparations, drugs for medical purposes, chemical preparations for pharmaceutical purposes, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; compounds for treating cancer; pharmaceuticals, medical and veterinary preparations for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; sanitary preparations for medical purposes; dietetic food and substances, namely, dietetic foods, sugar substitutes, nutritional beverages, and dietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materials, namely, gauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides
35 Retail pharmacy services; advertising services; business management; business administration services; providing office functions; information, advisory and consultancy services relating to all the aforesaid services
42 Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; information, advisory and consultancy services relating to all the aforesaid services
44 Pharmaceutical compounding services; providing medical information and information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical advice in the field of medicine, pharmacology, medical analysis and diagnostics; provision of medical services in the field of alternative medicine; providing medical information relating to medicine, pharmacology and medical diagnosis; medicine and treatment prescription services, namely, services relating to the diagnosis of illness and prescription of medicine; medicine and treatment prescription services, namely, home health care services, managed health care services; physical therapy services; medical diagnostic testing, monitoring and reporting services; medical services; veterinary services; hygienic and beauty salon and consultation services for human beings and animals; medicine and treatment prescription services, namely, insecticide spraying, vermin extermination for agriculture, horticulture and forestry; information, advisory and consultancy services relating to all the aforesaid services
Page 2, In the statement, line 31, "17-2028" should be deleted, and "16-2028" should be inserted, And, line 34, "10-2028" should be deleted, and "09-2018" should be inserted.
Color is not claimed as a feature of the mark.
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YAO YE"
The mark consists of a circle with four Chinese characters inside the circle.
The non-Latin characters in the mark transliterate to "kai tuo yao ye" and this means "expand pharmaceuticals" or "explore pharmaceuticals" in English.
The English translation of "kai tuo" in the mark is "expand" or "explore", and the English translation of "yao ye" in the mark is "pharmaceuticals".

Trademark Events
Mar 9, 2021
Correction Under Section 7 ¿ Processed
Mar 8, 2021
Teas Response To Office Action-Post Reg Received
Mar 4, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 4, 2021
Teas Change Of Correspondence Received
Mar 4, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 4, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 4, 2021
Teas Change Of Owner Address Received
Dec 9, 2020
Post Registration Action Mailed - Sec. 7
Dec 9, 2020
Case Assigned To Post Registration Paralegal
Sep 15, 2020
Teas Section 7 Request Received
Aug 18, 2020
Registered-Principal Register
Jul 16, 2020
1(B) Basis Deleted; Proceed To Registration
Jul 9, 2020
Notice Of Allowance Cancelled
Jul 9, 2020
Teas Delete 1(B) Basis Received
Apr 30, 2020
Notice Of Allowance Correction Entered
Apr 30, 2020
Case Assigned To Intent To Use Paralegal
Apr 3, 2020
Teas Post Publication Amendment Received
Feb 25, 2020
Noa E-Mailed - Sou Required From Applicant
Dec 31, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 31, 2019
Published For Opposition
Dec 11, 2019
Notification Of Notice Of Publication E-Mailed
Nov 22, 2019
Approved For Pub - Principal Register
Nov 22, 2019
Examiner's Amendment Entered
Nov 22, 2019
Notification Of Examiners Amendment E-Mailed
Nov 22, 2019
Examiners Amendment E-Mailed
Nov 22, 2019
Examiners Amendment -Written
Nov 22, 2019
Previous Allowance Count Withdrawn
Nov 5, 2019
Withdrawn From Pub - Og Review Query
Oct 21, 2019
Approved For Pub - Principal Register
Oct 15, 2019
Teas/Email Correspondence Entered
Oct 15, 2019
Correspondence Received In Law Office
Oct 14, 2019
Assigned To Lie
Oct 9, 2019
Teas Response To Suspension Inquiry Received
Jul 13, 2019
Notification Of Letter Of Suspension E-Mailed
Jul 13, 2019
Letter Of Suspension E-Mailed
Jul 13, 2019
Suspension Letter Written
Jul 9, 2019
Teas/Email Correspondence Entered
Jul 8, 2019
Correspondence Received In Law Office
Jul 8, 2019
Teas Response To Office Action Received
Jan 7, 2019
Notification Of Non-Final Action E-Mailed
Jan 7, 2019
Non-Final Action E-Mailed
Jan 7, 2019
Non-Final Action Written
Jan 2, 2019
Assigned To Examiner
Sep 28, 2018
Notice Of Design Search Code E-Mailed
Sep 27, 2018
New Application Office Supplied Data Entered In Tram
Sep 24, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24